Novartis AG is 174.8x more valuable than RAPT Therapeutics, Inc. by market capitalization ($293.70 B vs $1.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RAPT | NVS |
|---|---|---|
| Market cap | $1.68 B | $293.70 B |
| US-listed rank | #2241 | #46 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$129.87M | - |
| SEC filings | 569 | 947 |
Novartis AG is 174.8x more valuable than RAPT Therapeutics, Inc. by market capitalization ($293.70 B vs $1.68 B).
Full pages: RAPT Therapeutics, Inc. and Novartis AG, or browse the full rankings.